Although the importance of CD40L in prion disease progression has not yet been clarified (66–68), its downregulation in blood during both preclinical and clinical stages of atypical BSE-infection suggests that prion infection has an impact on the host immune system response and that immune tolerance may be an active process induced by prions. The gene discussed is CD40LG; the disease is prion disease.